Effect of Different Doses of Vitamin A on β-HCG Production in Patients Suffering from Gestational Trophoblastic Disease
Author(s) -
Shokoufeh Hosseini,
Masoumeh Yousefi,
Maryam Ebrahimi
Publication year - 2020
Publication title -
journal of advances in medical and biomedical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.113
H-Index - 12
ISSN - 2676-6264
DOI - 10.30699/jambs.28.128.151
Subject(s) - gestational trophoblastic disease , medicine , vitamin , obstetrics , disease , gestation , gynecology , trophoblastic neoplasm , pregnancy , endocrinology , biology , genetics
10.30699/jambs.28.128.151 Background & Objective: Gestational trophoblastic disease (GTD) is a type of disease which is characterized by increased production of B-HCG by placental cells. Increased β-HCG production is due to increased proliferation of beta cells and lack of apoptosis. If left untreated, it can lead to malignancy. Almost 30-50 of GTD progresses to gestational trophoblastic neoplasia (GTN) in women over 40 years old. This study aimed to evaluate the effect of vitamin A doses (100,000 IU and 200,000 IU) on the decrement of β-HCG levels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom